BCG as adjuvant immunotherapy for neoplasia.
D000818:Animals; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000628:therapy; D003110:Colonic Neoplasms / Q000628:therapy; D004195:Disease Models, Animal; D006258:Head and Neck Neoplasms / Q000628:therapy; D006801:Humans; D007111:Immunity, Cellular; D007938:Leukemia / Q000628:therapy; D007978:Levamisole / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008264:Macrophages / Q000276:immunology; D008545:Melanoma / Q000628:therapy; D012157:Mononuclear Phagocyte System / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000628:therapy
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D007978:Levamisole